Esperion Therapeutics (ESPR): Evaluating Valuation After $75 Million Equity Raise and Recent Share Price Volatility
Esperion Therapeutics (ESPR) just completed a $75 million follow-on equity offering, issuing 30 million shares at $2.50 each. This capital […]








